HomeNYMXF • OTCMKTS
add
Nymox Pharmaceutical Corp
Previous close
$0.050
Day range
$0.052 - $0.052
Year range
$0.00010 - $1.40
Market cap
4.86M USD
Avg Volume
22.68K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.85M | 387.66% |
Net income | -5.31M | -296.64% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.85M | -386.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.00K | -95.01% |
Total assets | 627.00K | -61.42% |
Total liabilities | 3.80M | 80.35% |
Total equity | -3.17M | — |
Shares outstanding | 93.54M | — |
Price to book | -1.67 | — |
Return on assets | -1,871.14% | — |
Return on capital | 562.12% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -5.31M | -296.64% |
Cash from operations | -897.00K | 28.18% |
Cash from investing | 0.00 | — |
Cash from financing | 891.00K | 1,813.46% |
Net change in cash | -6.00K | 99.54% |
Free cash flow | 720.55K | -35.25% |
About
Founded
1989
Website
Employees
3
